Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan — Atsushi Hiraoka (2019) | RDL Network
Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan
Article 2019 en
Authors
AH
Atsushi Hiraoka
KM
Kojiro Michitaka
TK
Takashi Kumada
Abstract
1 min read
Tumor marker score had a useful predictive prognostic value in BCLC-B HCC treated with TACE. Especially in patients with a tumor marker score of 2 or greater, a poor therapeutic response should be expected, and appropriate judgement of TACE-refractory status is necessary.
Ramya Ramaswami, David J. Pinato, Keiichi Kubota, Mitsuru Ishizuka, Tadaaki Arizumi, Masatoshi Kudo, Jeong Won Jang, Young Woon Kim, Mario Pirisi, Elias Allara, Rohini Sharma
Ramya Ramaswami, David J. Pinato, Keiichi Kubota, Mitsuru Ishizuka, Tadaaki Arizumi, Masatoshi Kudo, Jeong Won Jang, Young Woon Kim, Mario Pirisi, Elias Allara, Rohini Sharma
Masatoshi Kudo, Finn R.S., Manabu Morimoto, Rau K.-M., Masafumi Ikeda, Yen C.-J., Galle P.R., Llovet J.M., Bruno Daniele, Lim H.Y., M. W., Reigetsu Yoshikawa, Kenichi Nakamura, K. Liang, C. Wang, Paolo Abada, Widau R.C., Xiaoli Zhu
Discussion(0)
No comments yet. Be the first to comment.